Acute Myeloid Leukemia Therapeutics Market to 2020
|
|
- Stephany Lambert
- 8 years ago
- Views:
Transcription
1 Brochure More information from Acute Myeloid Leukemia Therapeutics Market to 2020 Description: Summary: Treatment and prognosis in AML is strongly influenced by a patient s age, and their cytogenetic profile. In the majority of cases these two prognostic influences are linked, with a higher frequency of unfavorable cytogenetic abnormalities observed in the elderly. Survival in this cohort of elderly patients is very poor, with a five year overall survival of 3 8% (Luger, 2010). Despite a relatively advanced understanding of genetic abnormalities associated with AML, the introduction of targeted therapies is lagging in this indication in comparison to other cancers such as breast and lung cancer, with no approved targeted therapies. Such slow development may be a reflection of AMLs status as an orphan indication. Intensive treatment in eligible patients (younger patients, and approximately 50% of diagnosed elderly patients) is typically the combination of the two chemotherapeutic agents cytarabine and daunorubicin, both of which were approved in the 1960s. In patients ineligible for intensive first-line chemotherapy, options are very poor, with the more recently approved Vidaza and Dacogen as the treatment options, which both offer unsatisfactory survival. Across all newly diagnosed patients that obtain complete remission, a stem cell transplant offers the highest chance of long-term survival. However, this procedure is risky, with a higher rate of treatment related mortality in the absence of better techniques to reduce the risk of graftversus-host disease. The majority of patients experience disease relapse, which is almost always fatal. Treatment options in these patients typically involve the off-label use of chemotherapeutic agents, whether in combination or as monotherapies. There are clear gaps in the market for therapies to meet several unmet needs by increasing the initial length of remission; improving treatment options for newly-diagnosed patients, ineligible for relapsed disease treatments; improving the success of and reducing the side effects of stem cell transplantation; and improving survival, safety and quality of life in patients with relapsed disease. The current developmental pipeline addresses these gaps in the market, along with the significant lack of targeted therapies. Five of the eight pipeline products are under development as non-intensive therapies for the elderly, and six of the eight products are being investigated in relapsed disease. Results so far have been mixed, with several drugs offering no overwhelming clinical benefit in Phase I and II clinical trials. Some drugs have demonstrated encouraging results namely CPX-351, quizartinib, StemEx, treosulfan and midostaurin. All of these drugs are forecast to be approved within the forecast period, a result of clinical trial data that suggest these drugs can offer improved survival in comparison to the currently marketed products. It is important to note however, that these improvements and the subsequent approval of these products is restricted to small patient cohorts including patients with secondary AML, those with internal tandem repeats in Fms-like tyrosine kinase, and patients eligible for a stem cell transplant, but for whom a matched donor cannot be found. This fragmentation in the treatment algorithm is a reflection of the heterogeneity of AML, with continued fractionation likely to be essential for further effective treatments to be developed. This is reflected in the current developmental pipeline, with drugs targeting a high variety of molecule types and molecular targets currently under investigation in this disease. The small patient cohorts the pipeline drugs are expected to be approved in will result in each having a minimal effect on any growth in market revenues over the forecast period. They will nevertheless stimulate market growth. An increase in prevalence and treatment populations, driven by aging populations across each territory will also have a positive effect on market revenues. However, as an orphan indication, the effect of population growth is also expected to have a minor effect. As a result, the global market revenues are forecast to rise at a limited CAGR of 4.8% from $632.4m in to $878.2m in Scope: The report analyzes treatment usage patterns, marketed and pipeline drugs, and market forecasts across indications for AML.The report covers and includes - - A brief introduction to AML, including the disease s pathogenesis, risk factors and diagnosis - An in-depth analysis of the drug combinations used in the treatment of AML, including analyses of their
2 safety, efficacy, and place in the disease treatment algorithm. This includes a heat map comparing the drug combinations in terms of safety and efficacy - A comprehensive review of the pipeline for AML therapies, including individual analysis of a number of latestage pipeline drugs that have the potential to enter the market during the forecast period. The pipeline is analyzed on the basis of Phase distribution, molecule types and molecular targets, as well as administration routes - An additional in-depth analysis of pipeline drug clinical trials by phase, trial size, trial duration and program failure rate analyses for each molecule type and molecular target - A multi-scenario forecast data for the market to 2020, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs and the changes in disease epidemiology across the key developed markets including the US, Canada, Japan, Germany, the UK, France, Italy and Spain - A discussion of the drivers and barriers for market growth - An in-depth analysis of licensing and co-development deals involving drugs indicated in AML, including an in-depth outline of the key deals Reasons to Purchase: The report will assist business development and enable marketing executives to strategize their product launches, by allowing them to - - Understand the efficacy and safety of the current monotherapies and drug combinations used in the treatment of AML, with in-depth analysis of the disease treatment algorithm - Understand the key signaling pathways and molecular targets currently under investigation in drug development for AML - Understand the vast scope of the pipeline, including which molecule types and molecular targets are most prominent - Observe the trends in clinical trial duration and size by clinical phase and molecule type, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for AML cancer therapeutics - Assess the potential clinical and commercial impact of current late-stage pipeline molecules in the AML therapeutics market - Assess the location of involved companies, and the value of both licensing and co-development deals involving drugs under investigation for the treatment of AML Contents: 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Disease Introduction 2.2 Epidemiology 2.3 Symptoms 2.4 Risk Factors Age Gender Smoking Chemotherapy or Radiation Therapy Benzene Previous Myelodysplastic Syndrome Chromosomal Disorders or Genetic Mutations 2.5 Diagnostic Techniques Blood Tests and Immunophenotyping Flow-Cytometry Cytogenetic Analysis Molecular Diagnostics 2.6 Pathophysiology 2.7 Diagnostic Criteria 2.8 Prognosis and Survival 3 Treatment Algorithm 3.1 Treatment of Acute Promyelocytic (M3) Leukemia is Effective, with High Cure Rates 3.2 Clinical Trial Response Criteria 3.3 Remission Induction Therapy
3 3.3.1 Intensive Remission Induction Therapy Non-intensive Remission Induction Therapy 3.4 Consolidation Therapy High- or Low-dose Cytarabine-based Therapy Stem Cell Transplantation 3.5 Remission Re-induction in Relapsed Disease Salvage Chemotherapy HSCT in Relapsed Disease 4 Commercial and Clinical Prospects of Marketed Products 4.1 Cytarabine 4.2 Daunorubicin 4.3 Idarubicin 4.4 Vidaza 4.5 Dacogen 4.6 Mitoxantrone 4.7 Etoposide 4.8 Fludarabine 4.9 Busulfan 4.10 Cyclophosphamide 4.11 Conclusion 5 Pipeline for Acute Myeloid Leukemia Therapeutics 5.1 Overview by Phase and Route of Administration 5.2 Overview by Molecule Type and Molecular Target 5.3 Key Molecular Targets in the Developmental Pipeline DNA Machinery Targets Targeted Therapies CD CD Wilm s Tumor Fms-Like Tyrosine Kinase 3 and its Downstream Pathway Components Discussion 5.4 Clinical Trials Clinical Trial Duration Clinical Trial Size Clinical Trial Failure Rates Discussion 5.5 Promising Drugs in AML Developmental Pipeline New Formulations Nucleoside analogues Stem Cell Therapy Conclusions 6 Market Forecasts 6.1 Global Treatment Usage Patterns Market Forecasts 6.2 North America US Canada 6.3 Top Five European Markets Epidemiology and Treatment Usage Patterns Annual Cost of Therapy Market Revenues 6.4 Japan Epidemiology and Treatment Usage Patterns Annual Cost of Therapy Market Forecast 7 Drivers and Barriers 7.1 Market Drivers High Level of Understanding of Genetic and Epigenetic Factors Underlying AML
4 7.1.2 High Number of Candidates in Drug Development Aging Population Orphan Designation High Degree of Clinical Trial Participation 7.2 Market Barriers Increasing Rates of Stem Cell Transplant High Heterogeneity of the Disease Lack of Standardized Treatment Market Heavily Dominated by Generics 8 Strategic Consolidations 8.1 Co-development Deals Ambit Biosciences Enters Co-development Agreement with Astellas Equity Financing of BioTheryX by Leukemia and Lymphoma Society Leukemia and Lymphoma Society Provide Funding for Celator s CPX Ascenta Therapeutics Enter Agreement with Leukemia and Lymphoma Society Stemline Therapeutics and MD Anderson Cancer Centre Enter Collaboration 8.2 Licensing Deals EpiCept Sells European Rights of Ceplene to Meda Biokine Therapeutics Out-License Development of BL-8040 to BioLineRx Tolero In-License alvocidib from Sanofi Bristol-Myers Squibb Enter Licensing Agreement with Innate Pharma for Lirilumab Cell Therapeutics Enters Licensing Agreement with Chroma Erytech Pharma Enters Licensing Agreement with Orphan Europe for Graspa 9 Appendix 9.1 All Pipeline Drugs by Phase Discovery Preclinical IND/CTA-Filed Phase I Phase II Phase III 9.2 Market Forecasts to Global The US Canada The UK France Germany Italy Spain Japan 9.3 References 9.4 Abbreviations 9.5 Research Methodology Secondary Research Marketed Product Profiles Late-Stage Pipeline Candidates Comparative Efficacy and Safety Heat Map for Marketed and Pipeline Products Product Competitiveness Framework Pipeline Analysis Forecasting Model Deals Data Analysis 9.6 Contact Us 9.7 Disclaimer 1.1 List of Tables Table 1: Acute Myeloid Leukemia Therapeutics, French-American-British Classification, Incidence (%) and Prognosis, Table 2: Acute Myeloid Leukemia Therapeutics, World Health Organization Classification, 2008 Table 3: Acute Myeloid Leukemia Therapeutics, Cytogenetic and Molecular Genetic Alterations and their Implications in Disease Prognosis
5 Table 4: Acute Myeloid Leukemia Therapeutics, Response Criteria (Remission or Treatment Failure) Table 5: Acute Myeloid Leukemia Therapeutics, Survival and Relapse Rates by Risk Category, Prognosis Table 6: Acute Myeloid Leukemia Therapeutics, Dosing Regimens of Conventional Care Regimes of Comparator Arm of One Phase III Clinical Trial of Vidaza, 2010 Table 7: Acute Myeloid Leukemia Therapeutics, Hazard Ratio for Allogeneic Stem Cell Transplants vs Chemotherapy and Autologous Stem Cell Transplant in Patients in First Remission, 2009 Table 8: Acute Myeloid Leukemia Therapeutics, Therapies Targeting CD123 in the Developmental Pipeline, Table 9: Acute Myeloid Leukemia Therapeutics, Therapies Targeting CD33 in the Developmental Pipeline, Table 10: Acute Myeloid Leukemia Therapeutics, Therapies Targeting Wilm s Tumor 1 in Developmental Pipeline, Table 11: Acute Myeloid Leukemia Therapeutics, Upstream and Downstream Pathway Components of FLT3, Table 12: Acute Myeloid Leukemia Therapeutics, Therapies Targeting FLT3 in Developmental Pipeline, Table 13: AML Therapeutics, Combination Therapies* in Current Developmental Pipeline Table 14: Acute Myeloid Leukemia Therapeutics, Dosing Schedules in One Phase II Trial of Qinprezo, 2010 Table 15: Acute Myeloid Leukemia Therapeutics, Results of a Phase II Clinical Trial of Midostaurin, 2009 Table 16: Acute Myeloid Leukemia Therapeutics, Therapies Targeting CD123 in the Developmental Pipeline, Table 17: Acute Myeloid Leukemia Therapeutics, Top Five European Markets, Annual Cost of Therapy, ($), 2020 Table 18: Market for AML, Global, Developmental Pipeline, Discovery, Table 19: Market for AML, Global, Developmental Pipeline, Preclinical, Table 20: Market for AML, Global, Developmental Pipeline, IND/CTA-Filed, Table 21: Market for AML, Global, Developmental Pipeline, Phase I, Table 22: Market for AML, Global, Developmental Pipeline, Phase II, Table 23: Market for AML, Global, Developmental Pipeline, Phase III, Table 24: Acute Myeloid Leukemia Market, Global, Market Forecasts, 2020 Table 25: Acute Myeloid Leukemia Market, US, Market Forecasts, 2020 Table 26: Acute Myeloid Leukemia Market, Canada, Market Forecasts, 2020 Table 27: Acute Myeloid Leukemia Market, UK, Market Forecasts, 2020 Table 28: Acute Myeloid Leukemia Market, France, Market Forecasts, 2020 Table 29: Acute Myeloid Leukemia Market, Germany, Market Forecasts, 2020 Table 30: Acute Myeloid Leukemia Market, Italy, Market Forecasts, 2020 Table 31: Acute Myeloid Leukemia Market, Spain, Market Forecasts, 2020 Table 32: Acute Myeloid Leukemia Market, Japan, Market Forecasts, List of Figures Figure 1: Acute Myeloid Leukemia Therapeutics, Efficacy Results for Key Parameters Marketed Products, Intensive Remission Induction Therapy Figure 2: Acute Myeloid Leukemia Therapeutics, Efficacy Results for Key Parameters Marketed Products, Non-Intensive Remission Induction Therapy Figure 3: Acute Myeloid Leukemia Therapeutics, Efficacy Results for Key Parameters Marketed Products, Salvage Therapy in Relapsed Disease Figure 4: Acute Myeloid Leukemia Therapeutics, Treatment Algorithm Figure 5: Acute Myeloid Leukemia Therapeutics, Global, Pipeline Distribution by Stage, Program Type and Route of Administration, Figure 6: Acute Myeloid Leukemia Therapeutics, Global, Pipeline by Molecule Type and Molecular Target, Figure 7: Acute Myeloid Leukemia Therapeutics, Global, Molecular Targets of Developmental Pipeline, Figure 8: Acute Myeloid Leukemia Therapeutics, Global, Clinical Trial Duration (Months), 2006 Figure 9: AML Therapeutics, Global, Clinical Trial Size (Participants), 2006 Figure 10: AML Therapeutics, Global, Clinical Trial Failure Rate and Reasons for Failure, 2006 Figure 11: Acute Myeloid Leukemia Therapeutics, Clinical Trial Heat Map Figure 12: Acute Myeloid Leukemia Therapeutics, Global, Forecast Revenues of CPX-351 ($m), Figure 13: Acute Myeloid Leukemia Therapeutics, Global, Forecast Revenues of Midostaurin ($m), Figure 14: Acute Myeloid Leukemia Therapeutics, Global, Forecast Revenues of Quizartinib ($m), Figure 15: Acute Myeloid Leukemia Therapeutics, Global, Forecast Revenues of StemEx ($m), Figure 16: Acute Myeloid Leukemia Therapeutics, Efficacy Results for Key Parameters Pipeline (Blue) and Marketed Products Comparison. Intensive Remission Induction Figure 17: Acute Myeloid Leukemia Therapeutics, Efficacy Results for Key Parameters Pipeline (Blue) and Marketed Products Comparison. Non-Intensive Remission Induction
6 Figure 18: Acute Myeloid Leukemia Therapeutics, Efficacy Results for Key Parameters Pipeline (Blue) and Marketed Products Comparison. Salvage Therapy for Relapsed Disease Figure 19: Acute Myeloid Leukemia Therapeutics, Global, Treatment Usage Patterns ( 000) and Market Revenues ($m), 2020 Figure 20: Acute Myeloid Leukemia Therapeutics, US, Treatment Usage Patterns ( 000) and Annual Cost of Therapy ($), 2020 Figure 21: Acute Myeloid Leukemia Therapeutics, US, Market Revenues ($m), 2020 Figure 22: Acute Myeloid Leukemia Therapeutics, Canada, Treatment Usage Patterns and ACoT ( 000; $), 2020 Figure 23: Acute Myeloid Leukemia Therapeutics, Canada, Market Revenues ($m), 2020 Figure 24: Acute Myeloid Leukemia Therapeutics, Top Five European Markets, Treatment Usage Patterns ( 000), 2020 Figure 25: Acute Myeloid Leukemia Therapeutics, Top Five European Markets, Annual Cost of Therapy ($), 2020 Figure 26: Acute Myeloid Leukemia Therapeutics,Top Five European Markets, Market Revenues ($m), 2020 Figure 27: Acute Myeloid Leukemia Therapeutics, Japan, Treatment Usage Patterns and Annual Cost of Therapy ( 000; $), 2020 Figure 28: Acute Myeloid Leukemia Therapeutics, Japan, Market Revenues ($m), 2020 Figure 29: Acute Myeloid Leukemia Therapeutics, Global, Co-development Deals, 2006 Figure 30: Acute Myeloid Leukemia Therapeutics, Global, Co-development Deals (Molecule Type and Mechanism of Action), 2006 Figure 31: Acute Myeloid Leukemia Therapeutics, Global, Licensing Deals by Region, 2006 Figure 32: Acute Myeloid Leukemia Therapeutics, Global, Licensing Deals by Value and Year, 2006 Figure 33: Acute Myeloid Leukemia Therapeutics, Global, Licensing Deals by Molecule Type and Mechanism of Action, Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.
7 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Acute Myeloid Leukemia Therapeutics Market to 2020 Web Address: Office Code: Product Formats Please select the product formats and quantity you require: SC Electronic (PDF) - Single User: Electronic (PDF) - Site License: Electronic (PDF) - Enterprisewide: Quantity USD 4995 USD 9990 USD Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)
8 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World
Stakeholder Insight: Acute Leukemias - Reaching the Limits of Cytotoxic Chemotherapy
Brochure More information from http://www.researchandmarkets.com/reports/1088137/ Stakeholder Insight: Acute Leukemias - Reaching the Limits of Cytotoxic Chemotherapy Description: The drug therapy of acute
More informationGlobal Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070277/ Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of
More informationGlobal Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070278/ Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of
More informationGlobal Haemophilia Epidemiology and Patient Flow Analysis - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3070298/ Global Haemophilia Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of its Haemophilia
More informationAvastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2228475/ Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Description: Avastin (Renal Cell Carcinoma) Analysis and
More informationXarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2152222/ Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022 Description: Xarelto (Atrial Fibrillation) Analysis and
More informationUlcerative colitis Pipeline Highlights - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3031128/ Ulcerative colitis Pipeline Highlights - 2015 Description: The latest report Ulcerative colitis Pipeline Highlights 2015
More informationEurope Rheumatoid Arthritis Market Highlights - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3447138/ Europe Rheumatoid Arthritis Market Highlights - 2015 Description: The latest research, 'Europe Rheumatoid Arthritis Market
More informationGlobal Opioid Dependence Drugs Market Highlights - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3293542/ Global Opioid Dependence Drugs Market Highlights - 2015 Description: The latest research Global Opioid Dependence Drugs
More informationSinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2834728/ Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Description: Sinemet (Parkinson s Disease) - Forecast
More informationMultiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
More informationREFERENCE CODE GDHC003POA PUBLICAT ION DATE AUGUST 2013
REFERENCE CODE GDHC003POA PUBLICAT ION DATE AUGUST 2013 ACUTE MYELOID LEUKEMIA (AML) - Executive Summary AML: Key Metrics in Six Major Pharmaceutical Markets, 2012 2017 2012 Epidemiology Incident Population
More informationRenal Cell Carcinoma (Event Driven)
Brochure More information from http://www.researchandmarkets.com/reports/2365661/ Renal Cell Carcinoma (Event Driven) Description: The Renal Cell Carcinoma market is highly lucrative. We anticipate that
More informationMultiple Myeloma (Event Driven)
Brochure More information from http://www.researchandmarkets.com/reports/2234830/ Multiple Myeloma (Event Driven) Description: The 2010 multiple myeloma (myeloma) market garnered impressive sales despite
More informationWest Nile Virus Infections-Pipeline Insights, 2016
Brochure More information from http://www.researchandmarkets.com/reports/3533615/ West Nile Virus Infections-Pipeline Insights, 2016 Description: West Nile Virus Infections-Pipeline Insights, 2016 provides
More informationAcute Myeloid Leukemia Therapeutics Market to 2020. Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
Acute Myeloid Leukemia Therapeutics Market to 2020 Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts GBI Research Report Guidance GBI Research Report Guidance The report begins with an
More informationRhino-Conjunctivitis Global Clinical Trials Review, H1, 2016
Brochure More information from http://www.researchandmarkets.com/reports/3625161/ Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2016 Description: Rhino-Conjunctivitis Global Clinical Trials Review,
More informationGlobal Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
More informationMethotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
Brochure More information from http://www.researchandmarkets.com/reports/3128342/ Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Description: Methotrexate (Rheumatoid Arthritis)
More informationEuropean Electronic Medical Records (EMR) Markets
Brochure More information from http://www.researchandmarkets.com/reports/470558/ European Electronic Medical Records (EMR) Markets Description: This Frost & Sullivan research service titled European Electronic
More informationGastric Cancer. Brochure More information from http://www.researchandmarkets.com/reports/2228929/
Brochure More information from http://www.researchandmarkets.com/reports/2228929/ Gastric Cancer Description: Gastric cancer (GC) is one of the most common malignancies in terms of incidence and the second
More informationSmall-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
More informationFondazione Neoplasie Sangue Onlus - Developmental Therapeutics Review - Q4 2010
Brochure More information from http://www.researchandmarkets.com/reports/1464350/ Fondazione Neoplasie Sangue Onlus - Developmental Therapeutics Review - Q4 2010 Description: Fondazione Neoplasie Sangue
More informationTreating Refractory Hematological Malignancies Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging Therapeutics
Brochure More information from http://www.researchandmarkets.com/reports/2635096/ Treating Refractory Hematological Malignancies Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging
More informationAnalysis of the Global Enterprise Firewall Market
Brochure More information from http://www.researchandmarkets.com/reports/2238954/ Analysis of the Global Enterprise Firewall Market Description: Next-generation Technologies Protect Businesses from Advanced
More informationPortal Hypertension Global Clinical Trials Review, H1, 2016
Brochure More information from http://www.researchandmarkets.com/reports/3618524/ Portal Hypertension Global Clinical Trials Review, H1, 2016 Description: Portal Hypertension Global Clinical Trials Review,
More informationTehran University of Medical Sciences - Developmental Therapeutics Review - Q4 2010
Brochure More information from http://www.researchandmarkets.com/reports/1464053/ Tehran University of Medical Sciences - Developmental Therapeutics Review - Q4 2010 Description: Tehran University of Medical
More informationWorld Enterprise, Broadband, Mobile Video Transcoders Market
Brochure More information from http://www.researchandmarkets.com/reports/1061156/ World Enterprise, Broadband, Mobile Video Transcoders Market Description: Encoding is defined as the process of turning
More informationGlobal Big Data Analytics Market for Test and Measurement
Brochure More information from http://www.researchandmarkets.com/reports/3420825/ Global Big Data Analytics Market for Test and Measurement Description: Big Data analytics for test and measurement (T&M)
More informationU.S. Call Center Software Markets
Brochure More information from http://www.researchandmarkets.com/reports/358405/ U.S. Call Center Software Markets Description: All types of call center software are continuing to rapidly gain popularity,
More informationGlobal Change and Configuration Management Software Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3129431/ Global Change and Configuration Management Software Market 2015-2019 Description: About Change and Configuration Management
More informationGlobal Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/1054840/ Global Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive Growth Description: Global ECG
More informationXarelto-Drug Insights,2014
Brochure More information from http://www.researchandmarkets.com/reports/2977191/ Xarelto-Drug Insights,2014 Description: Xarelto - Drug Insights, 2014 provides Xarelto marketed details and API Manufacturers
More informationInsulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020
Brochure More information from http://www.researchandmarkets.com/reports/2075322/ Insulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020 Description: Insulin Degludec (Type 2 Diabetes) Analysis
More informationWorld Wireless Protocol Analyzers and Network Monitoring Systems
Brochure More information from http://www.researchandmarkets.com/reports/1443662/ World Wireless Protocol Analyzers and Network Monitoring Systems Description: This research service provides the key research
More informationTrends and Opportunities in the UAE Life Insurance Industry to 2016: Market Profile
Brochure More information from http://www.researchandmarkets.com/reports/2403273/ Trends and Opportunities in the UAE Life Insurance Industry to 2016: Market Profile Description: Synopsis The report provides
More information"Personal Accident and Health Insurance Claims and Expenses in Morocco to 2018: Market Databook"
Brochure More information from http://www.researchandmarkets.com/reports/3064340/ Personal Accident and Health Insurance Claims and Expenses in Morocco to 2018: Market Databook Description: "Personal Accident
More informationGlobal Insurance Brokerage Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2987445/ Global Insurance Brokerage Market 2014-2018 Description: About Insurance Brokerage Insurance brokers play a vital role
More informationGlobal Customer Cloud App Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2757571/ Global Customer Cloud App Market 2014-2018 Description: The analysts forecast the Global Customer Cloud App market to grow
More informationNon-life Insurance IT Solutions Europe 2014-2015
Brochure More information from http://www.researchandmarkets.com/reports/2687950/ Non-life Insurance IT Solutions Europe 2014-2015 Description: Non-life Insurance IT Solutions Europe 2014-2015 - Current
More informationGlobal Big Data Storage and Server Market 2012-2016
Brochure More information from http://www.researchandmarkets.com/reports/2644662/ Global Big Data Storage and Server Market 2012-2016 Description: The analysts forecast the Global Big Data Storage and
More informationMultiple Sclerosis Treatment Market: Opportunities for Oral Drugs
Brochure More information from http://www.researchandmarkets.com/reports/706246/ Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs Description: Only about 36% of Multiple Sclerosis (MS)
More information'Personal Accident and Health Insurance Premiums and Claims in Australia to 2018: Market Brief' contains
Brochure More information from http://www.researchandmarkets.com/reports/3064493/ Personal Accident and Health Insurance Premiums and Claims in Australia to : Market Brief Description: 'Personal Accident
More informationTrends and Opportunities in Cambodia Personal Accident and Health Insurance Industry to 2017: Market Profile
Brochure More information from http://www.researchandmarkets.com/reports/2729290/ Trends and Opportunities in Cambodia Personal Accident and Health Insurance Industry to 2017: Market Profile Description:
More informationEuropean Healthcare Analytics Market - Growth, Trends & Forecast To 2020
Brochure More information from http://www.researchandmarkets.com/reports/3105899/ European Healthcare Analytics Market - Growth, Trends & Forecast To 2020 Description: The European market for Healthcare
More informationStrategic Analysis of Fleet Vehicle Leasing Market in Ireland
Brochure More information from http://www.researchandmarkets.com/reports/3629286/ Strategic Analysis of Fleet Vehicle Leasing Market in Ireland Description: The objective of this study is to provide a
More informationAnalysis of the European Infrastructure-as-a-Service Market
Brochure More information from http://www.researchandmarkets.com/reports/3162741/ Analysis of the European Infrastructure-as-a-Service Market Description: Increased enterprise migration from on-premise
More informationPublic Cloud Computing Market for SMBs in India - Affordable Connectivity and Virtualization Technologies to Drive Adoption of Public Cloud
Brochure More information from http://www.researchandmarkets.com/reports/2643414/ Public Cloud Computing Market for SMBs in India - Affordable Connectivity and Virtualization Technologies to Drive Adoption
More informationPediatric Trials: Patient Recruitment Best Practices
Brochure More information from http://www.researchandmarkets.com/reports/3261623/ Pediatric Trials: Patient Recruitment Best Practices Description: Recruiting clinical trial participants is hard. Recruiting
More informationGlobal Physical Security Information Management Market Assessment
Brochure More information from http://www.researchandmarkets.com/reports/2776367/ Global Physical Security Information Management Market Assessment Description: The physical security information management
More informationSienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update
Brochure More information from http://www.researchandmarkets.com/reports/2870367/ Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update Description: Summary Sienna Cancer Diagnostics Ltd.
More informationNext Generation Enterprise Mobility Management Market Insight
Brochure More information from http://www.researchandmarkets.com/reports/2858620/ Next Generation Enterprise Mobility Management Market Insight Description: Mobile Device Management (MDM) solutions are
More informationPersonal Accident and Health Insurance Claims and Expenses in Belarus to 2016: Market Databook
Brochure More information from http://www.researchandmarkets.com/reports/2500010/ Personal Accident and Health Insurance Claims and Expenses in Belarus to 2016: Market Databook Description: Synopsis Timetric
More informationStrategic Analysis of the Impact of Big Data on the European and North American Automotive Industry
Brochure More information from http://www.researchandmarkets.com/reports/2764190/ Strategic Analysis of the Impact of Big Data on the European and North American Automotive Industry Description: The aim
More information'Personal Accident and Health Insurance Premiums and Claims in Kenya to 2018: Market Brief' contains
Brochure More information from http://www.researchandmarkets.com/reports/3087330/ Personal Accident and Health Insurance Premiums and Claims in Kenya to 2018: Market Brief Description: 'Personal Accident
More informationOvarian Cancer (Event Driven)
Brochure More information from http://www.researchandmarkets.com/reports/2367241/ Ovarian Cancer (Event Driven) Description: Owing to the lack of screening programs across the markets under study, ovarian
More informationSocial Media: Best Practices and Strategic Use in Patient Recruitment
Brochure More information from http://www.researchandmarkets.com/reports/2739687/ Social Media: Best Practices and Strategic Use in Patient Recruitment Description: One BILLION - with a B - Facebook users?
More informationGlobal and Chinese Polypropylene carbonate (PPC) Industry - 2009-2019
Brochure More information from http://www.researchandmarkets.com/reports/3034018/ Global and Chinese Polypropylene carbonate (PPC) Industry - 2009-2019 Description: Global and Chinese Polypropylene carbonate
More informationAccounting, Tax Preparation, Bookkeeping, and Payroll Services - The 2016 U.S. Market Research Report
Brochure More information from http://www.researchandmarkets.com/reports/3612891/ Accounting, Tax Preparation, Bookkeeping, and Payroll Services - The 2016 U.S. Market Research Report Description: This
More informationBreast Cancer Drug Discoveries: What the Future Holds
Brochure More information from http://www.researchandmarkets.com/reports/679630/ Breast Cancer Drug Discoveries: What the Future Holds Description: In 2010, almost 50% of breast cancer sales were due to
More informationIP VPN Market Forecast in India to 2016
Brochure More information from http://www.researchandmarkets.com/reports/1772777/ IP VPN Market Forecast in India to 2016 Description: This databook analyzes and provides forecasts for the Internet Protocol-enabled
More informationPersonal Accident and Health Insurance Claims and Expenses in South Africa to 2017: Market Databook
Brochure More information from http://www.researchandmarkets.com/reports/2654413/ Personal Accident and Health Insurance Claims and Expenses in South Africa to 2017: Market Databook Description: Synopsis
More informationLife Insurance Distribution Channels in Croatia to 2019: Market Databook
Brochure More information from http://www.researchandmarkets.com/reports/3500216/ Life Insurance Distribution Channels in Croatia to 2019: Market Databook Description: The "Life Insurance Distribution
More informationNon-Life Insurance Premiums and Claims in Georgia to 2017: Market Brief
Brochure More information from http://www.researchandmarkets.com/reports/2697018/ Non-Life Insurance Premiums and Claims in Georgia to 2017: Market Brief Description: Synopsis 'Non-Life Insurance Premiums
More informationNon-Life Insurance Premiums and Claims in Brazil to 2018: Market Brief
Brochure More information from http://www.researchandmarkets.com/reports/3022663/ Non-Life Insurance Premiums and Claims in Brazil to 2018: Market Brief Description: 'Non-Life Insurance Premiums and Claims
More information- Contains an executive summary and data on value, volume and/or segmentation
Brochure More information from http://www.researchandmarkets.com/reports/368198/ Used Cars in Europe Description: The Used Cars in Europe industry profile is an essential resource for top-level data and
More informationBrochure More information from http://www.researchandmarkets.com/reports/2860999/
Brochure More information from http://www.researchandmarkets.com/reports/2860999/ Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer
More informationIron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment,
Brochure More information from http://www.researchandmarkets.com/reports/2980507/ Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Description: Iron Deficiency
More informationGlobal Medical Practice Management Software Market Outlook: 2014-2020
Brochure More information from http://www.researchandmarkets.com/reports/3159021/ Global Medical Practice Management Software Market Outlook: 2014-2020 Description: Medical practice management software
More informationEquipment Finance Market in the US 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/3022227/ Equipment Finance Market in the US 2014-2018 Description: About Equipment Finance In the US, a large number of businesses
More informationCustomer Relationship Management (CRM) Analytics Global Market Analysis - Forecast (2014-2020)
Brochure More information from http://www.researchandmarkets.com/reports/3164949/ Customer Relationship Management (CRM) Analytics Global Market Analysis - Forecast (2014-2020) Description: The report
More informationEnterprise VoIP - Future Potential of the Indian Market for Managed VoIP Solutions
Brochure More information from http://www.researchandmarkets.com/reports/2966201/ Enterprise VoIP - Future Potential of the Indian Market for Managed VoIP Solutions Description: The study provides comprehensive
More informationNorth American Video Conferencing Hosted and Managed Services Market: Growing Amidst a Long-term Transition and Economic Turbulence
Brochure More information from http://www.researchandmarkets.com/reports/2498908/ North American Video Conferencing Hosted and Managed Services Market: Growing Amidst a Long-term Transition and Economic
More informationNorth America Insurance Market Outlook to 2015 - US Insurance Market Headstarting the Lost Momentum
Brochure More information from http://www.researchandmarkets.com/reports/1545614/ North America Insurance Market Outlook to 2015 - US Insurance Market Headstarting the Lost Momentum Description: The Report
More informationPersonal Accident and Health Insurance Investments in Russia to 2018: Market Databook
Brochure More information from http://www.researchandmarkets.com/reports/3035895/ Personal Accident and Health Insurance Investments in Russia to : Market Databook Description: "Personal Accident and Health
More informationVisioneering Technologies, Inc. - Product Pipeline Analysis
Brochure More information from http://www.researchandmarkets.com/reports/1448007/ Description: Summary Visioneering Technologies, Inc. (Visioneering) is engaged in providing solutions for correcting presbyopia
More informationCommercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019
Brochure More information from http://www.researchandmarkets.com/reports/1314569/ Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive
More informationMultiple Sclerosis Treatments: World Market Outlook to 2011
Brochure More information from http://www.researchandmarkets.com/reports/2860814/ Multiple Sclerosis Treatments: World Market Outlook to 2011 Description: Multiple sclerosis (MS) is a chronic demyelinating
More informationGlobal Marketing Automation Software Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2763337/ Global Marketing Automation Software Market 2014-2018 Description: The analysts forecast the Global Marketing Automation
More informationPharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022. Multiple
Brochure More information from http://www.researchandmarkets.com/reports/2541548/ PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 Description: PharmaPoint: Multiple
More informationAPAC Contract Research Organisation (CRO) Market
Brochure More information from http://www.researchandmarkets.com/reports/3308444/ APAC Contract Research Organisation (CRO) Market Description: The research service presents an overview and analysis of
More informationGlobal Air Ambulance Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3085023/ Global Air Ambulance Market 2015-2019 Description: About Air Ambulance Air ambulance services are sophisticated and advanced
More informationBusiness Schools and Computer and Management Training - The 2015 U.S. Market Research Report
Brochure More information from http://www.researchandmarkets.com/reports/3243866/ Business Schools and Computer and Management Training - The 2015 U.S. Market Research Report Description: This 2015 Market
More informationExpanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurological Disease
Brochure More information from http://www.researchandmarkets.com/reports/363610/ Expanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurological Disease Description: The repositioning of agents
More informationGlobal Virtual Desktop Infrastructure (VDI) Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2716882/ Global Virtual Desktop Infrastructure (VDI) Market 2014-2018 Description: The analysts forecast the Global Virtual Desktop
More informationCorMedix, Inc. (CRMD) - Product Pipeline Analysis
Brochure More information from http://www.researchandmarkets.com/reports/1595808/ Description: Summary CorMedix, Inc. (CorMedix) is a pharmaceutical company, based in the US. It develops and seeks to commercialize
More informationGlobal Big Data Analytics Market
Brochure More information from http://www.researchandmarkets.com/reports/2872293/ Global Big Data Analytics Market Description: This report classifies all analytics solutions into 2 broad segments, namely
More informationAnalysis of the Commercial Flight Training and Simulation Market
Brochure More information from http://www.researchandmarkets.com/reports/1870413/ Analysis of the Commercial Flight Training and Simulation Market Description: This study covers the market for pilot training
More informationBP p.l.c. (BP) Company Profile- Business Overview, Strategies, SWOT and Financial Analysis
Brochure More information from http://www.researchandmarkets.com/reports/1504211/ BP p.l.c. (BP) Company Profile- Business Overview, Strategies, SWOT and Financial Analysis Description: BP p.l.c. (BP)
More informationMultiple Sclerosis Drug Discoveries - What the Future Holds
Brochure More information from http://www.researchandmarkets.com/reports/1408035/ Multiple Sclerosis Drug Discoveries - What the Future Holds Description: The recent approval in the US of Novartis' orally
More informationLeukemia Drug Pathway Analyzer
Brochure More information from http://www.researchandmarkets.com/reports/2673689/ Leukemia Drug Pathway Analyzer Description: Extra value: One year of free online updates included with this product There
More informationU.S. Database Management System Software by Vertical Market
Brochure More information from http://www.researchandmarkets.com/reports/365475/ U.S. Database Management System Software by Vertical Market Description: Driven by the inherent need for businesses of all
More informationGlobal Document Management Systems (DMS) Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2933789/ Global Document Management Systems (DMS) Market 2014-2018 Description: About Document Management Systems Document management
More informationEstonia: Clay Tiles And Roofing - Market Report. Analysis And Forecast To 2020
Brochure More information from http://www.researchandmarkets.com/reports/3115162/ Estonia: Clay Tiles And Roofing - Market Report. Analysis And Forecast To 2020 Description: The report provides an in-depth
More informationHot Topic Healthcare IT Trends in Brazil
Brochure More information from http://www.researchandmarkets.com/reports/3088843/ Hot Topic Healthcare IT Trends in Brazil Description: In this study, Frost & Sullivan identifies key areas across the healthcare
More informationOveractive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Brochure More information from http://www.researchandmarkets.com/reports/3533933/ Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 Description: SUMMARY The Report,
More informationConnected Home for Insurers
Brochure More information from http://www.researchandmarkets.com/reports/3456227/ Connected Home for Insurers Description: The Connected Home: implication for insurers is the first research available on
More informationGlobal Social Customer Relationship Management (CRM) Software Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3093584/ Global Social Customer Relationship Management (CRM) Software Market 2015-2019 Description: About Social CRM Social CRM
More informationELITech Group - Product Pipeline Analysis
Brochure More information from http://www.researchandmarkets.com/reports/2351170/ ELITech Group - Product Pipeline Analysis Description: Summary The Elitech Group (Elitech Group) is a medical device company,
More informationHeadaches: Current Treatments, Unmet Needs, and Patient Recruitment
Brochure More information from http://www.researchandmarkets.com/reports/3023234/ Headaches: Current Treatments, Unmet Needs, and Patient Recruitment Description: This report identifies and explores the
More information